Showing results (21-30 of 2,459) with videos related to
Sort By:
Pageof 246
Statistics in Medicine|July 11, 2003
On the analysis of viral load endpoints in HIV vaccine trialsMichael G Hudgens, Antje Hoering, Steven G SelfBMC Research Notes|January 28, 2014
Finding gene clusters for a replicated time course studyLi-Xuan Qin, Linda Breeden, Steven G SelfStatistics in Medicine|April 27, 2010
Some design issues in phase 2B vs phase 3 prevention trials for testing efficacy of products or conceptsPeter B GilbertStatistical Communications in Infectious Diseases|December 14, 2020
Ongoing Vaccine and Monoclonal Antibody HIV Prevention Efficacy Trials and Considerations for Sequel Efficacy Trial DesignsPeter B GilbertStatistical Communications in Infectious Diseases|December 15, 2010
Increasing the Efficiency of Prevention Trials by Incorporating Baseline CovariatesMin Zhang, Peter B GilbertEpidemiologic Methods|February 4, 2017
Predicting Overall Vaccine Efficacy in a New Setting by Re-Calibrating Baseline Covariate and Intermediate Response Endpoint Effect Modifiers of Type-Specific Vaccine EfficacyPeter B Gilbert, Ying HuangLifetime Data Analysis|October 30, 2015
Mark-specific hazard ratio model with missing multivariate marksMichal Juraska, Peter B GilbertJournal of the Royal Statistical Society. Series C, Applied Statistics|February 3, 2015
Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to HIV vaccine efficacy trialsPeter B Gilbert, Yanqing SunBiometrics|December 24, 2002
Flexible weighted log-rank tests optimal for detecting early and/or late survival differencesLang Wu, Peter B GilbertBiostatistics (Oxford, England)|October 10, 2009
Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome dataPeter B Gilbert, Yuying JinPageof 246